IRIS
CONTI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.800
AS - Asia 7.098
EU - Europa 6.489
SA - Sud America 1.457
AF - Africa 402
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 6
Totale 24.266
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.503
SG - Singapore 2.952
CN - Cina 2.391
BR - Brasile 1.155
IE - Irlanda 1.077
DE - Germania 1.065
FI - Finlandia 870
UA - Ucraina 859
SE - Svezia 831
IT - Italia 730
VN - Vietnam 593
HK - Hong Kong 547
NL - Olanda 306
ZA - Sudafrica 289
CA - Canada 218
TR - Turchia 189
AT - Austria 171
GB - Regno Unito 152
RU - Federazione Russa 133
AR - Argentina 119
FR - Francia 91
IN - India 78
EC - Ecuador 64
JP - Giappone 59
BD - Bangladesh 51
MX - Messico 51
BE - Belgio 43
ID - Indonesia 38
IQ - Iraq 37
ES - Italia 34
PL - Polonia 33
CO - Colombia 28
MA - Marocco 27
KR - Corea 26
VE - Venezuela 26
PY - Paraguay 24
KE - Kenya 22
PK - Pakistan 22
CZ - Repubblica Ceca 21
LT - Lituania 18
EG - Egitto 16
UZ - Uzbekistan 15
IL - Israele 13
UY - Uruguay 13
EU - Europa 12
CI - Costa d'Avorio 11
CL - Cile 10
JO - Giordania 10
NP - Nepal 10
PE - Perù 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 7
BG - Bulgaria 7
BO - Bolivia 7
SA - Arabia Saudita 7
TN - Tunisia 7
CR - Costa Rica 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
RO - Romania 6
BJ - Benin 5
BY - Bielorussia 5
CH - Svizzera 5
RS - Serbia 5
BH - Bahrain 4
LB - Libano 4
OM - Oman 4
TG - Togo 4
AO - Angola 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
JM - Giamaica 3
KW - Kuwait 3
LU - Lussemburgo 3
LV - Lettonia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
ZW - Zimbabwe 3
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 24.241
Salva come PNG Salva come JPEG
Città #
Singapore 1.413
Dublin 1.067
Jacksonville 968
Ashburn 898
Chandler 885
Beijing 635
Dallas 558
Hong Kong 542
Santa Clara 522
Dearborn 403
Boardman 357
Nanjing 338
Ann Arbor 332
Johannesburg 268
Bremen 260
Princeton 259
San Mateo 248
Ho Chi Minh City 228
Parma 219
Munich 206
New York 162
Vienna 161
Toronto 154
Helsinki 149
Izmir 147
Los Angeles 141
Wilmington 135
Shanghai 123
Hanoi 119
Des Moines 118
Shenyang 114
Hefei 112
Moscow 97
Kunming 95
Hebei 93
São Paulo 92
Nanchang 87
Jinan 69
Buffalo 58
Woodbridge 58
Seattle 54
Marseille 53
Columbus 51
Grafing 51
Turku 51
Changsha 46
Düsseldorf 45
Guangzhou 44
Tianjin 44
Brussels 41
Milan 40
Tokyo 36
Jiaxing 35
Haiphong 33
Houston 32
Rio de Janeiro 32
Council Bluffs 30
Brooklyn 29
The Dalles 29
Fremont 28
Warsaw 28
Da Nang 27
Quito 26
Denver 25
Zhengzhou 25
Norwalk 24
Seoul 24
Hangzhou 23
Atlanta 22
London 22
Montreal 22
Orem 22
Brasília 21
Chennai 21
Jakarta 21
Nuremberg 20
Porto Alegre 20
Curitiba 19
Frankfurt am Main 19
Belo Horizonte 18
Nairobi 18
San Francisco 18
Phoenix 17
Salvador 16
Amsterdam 15
Biên Hòa 15
Bắc Ninh 15
Reggio Nell'emilia 15
Borås 14
Boston 14
Buenos Aires 14
Campinas 14
Guayaquil 14
Hải Dương 14
Istanbul 13
Modena 13
Osasco 13
Ottawa 13
Rome 13
Stockholm 13
Totale 14.434
Salva come PNG Salva come JPEG
Nome #
A transphyletic anti-infectious control strategy based on the killer phenomenon. 254
Antibacterial effects of two synthetic peptides against Enterococcus faecalis biofilms: A preliminary in vitro study 186
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 179
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 178
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 176
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 175
Candidacidal activity of a novel killer toxin from Wickerhamomyces anomalus against fluconazole-susceptible and -resistant strains 173
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 170
Antibodies as a source of anti-infective peptides: an update 163
Activity of two antimicrobial peptides against Enterococcus faecalis in a model of biofilm-mediated endodontic infection 159
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 158
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 156
Antimicrobial peptide L18R displays a modulating action against inter-kingdom biofilms in the Lubbock chronic wound biofilm model 154
Anti-Staphylococcus aureus Activity and Structural Characterization of Rationally Designed Peptides 153
L’antibiogramma per i miceti 151
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 150
Antifungal peptides within the antibodies 150
A synthetic peptide as a novel anticryptococcal agent 149
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 148
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 147
Metabolic profiling of Candida albicans 145
Fungicidal activity of peptides encoded by immunoglobulin genes 144
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 143
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 143
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 141
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 139
Antifungal activity of the C-terminal peptide from human serum albumin 136
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 136
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 136
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 134
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BIOFILMS WITH DIFFERENT WAVELENGTHS AND DYES WITH SYNTHETIC KILLER DECAPEPTIDE 133
Anaerobic yeast killer system. 132
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 132
Peptides from the inside of the antibodies are active against infectious agents and tumours 132
Antibody peptide based antifungal immunotherapy 131
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 131
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 129
Antibody-mediated protective immunity in fungal infections 129
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 129
Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study 128
Activity of Synthetic Peptide KP and Its Derivatives against Biofilm-Producing Escherichia coli Strains Resistant to Cephalosporins 128
Natural and synthetic peptides with antifungal activity 128
Antimicrobial effect on candida albicans biofilm bapplication of different wavelengths and dyes and the synthetic killer decapeptide KP 127
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 127
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 126
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 123
Anticorpi immagini interne di tossine killer 123
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 122
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 121
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 120
Antimicrobial photodynamic therapy protocols on streptococcus mutans with different combinations of wavelengths and photosensitizing dyes 119
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 118
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 118
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 118
Novel Arginine- and Proline-Rich Candidacidal Peptides Obtained through a Bioinformatic Approach 117
Detection of Mycobacterium bovis in bovine tissue samples by the Abbott LCx Mycobacterium tuberculosis assay and comparison with culture methods 117
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 117
A Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species 116
Antireceptor yeast killer toxin-like antibiobodies 115
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 115
Wickerhamomyces yeast killer toxins’ medical applications 115
Antibiobodies: antibiotic-like antiidiotypic antibodies. 113
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 112
Antibiobodies: antibiotic internal image antibodies 111
Valutazione del sistema Bactec Mycobacterial Growth Indicator Tube (MGIT) 960 per il rilevamento di micobatteri dai materiali patologici in comparazione ai metodi radiometrico e tradizionale 111
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 111
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 110
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 109
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 109
Mode of action of a killer peptide against Toxoplasma gondii 109
Innate antimicrobial and antiviral activities of antibody peptides 108
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 108
In vitro and in vivo anticandidal activity of killer peptide derivatives 107
Allergic bronchopulmonary aspergillosis: An important cause of asthma which is sometimes ignored 107
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 106
Guideline for the analysis of the microbial communities of the human upper airways 105
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 105
Metabolic Plasticity of Candida albicans in Response to Different Environmental Conditions 105
The Variability of the Salivary Antimicrobial Peptide Profile: Impact of Lifestyle 104
Metabolic profile of Candida albicans 104
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 101
Antibodies as Crypts of Antiinfective and Antitumor Peptides 100
Antibiotic antibodies 100
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 99
Marcatori epidemiologici. 99
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 97
Restriction of Influenza virus multiplication induced by PK peptide treatment 97
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 97
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 96
The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action 96
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 95
A Wickerhamomyces anomalus killer strain in the malaria vector Anopheles stephensi 95
Immagine interna del fenomeno killer dei lieviti 94
Yeast killer toxins and dimorphism. 94
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. 94
Biotipizzazione di microorganismi patogeni mediante il sistema killer dei lieviti. 93
Any antibody fragment might exert antifungal activity 93
Protective antifungal yeast killer toxin-like antibodies 92
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 92
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity 91
Totale 12.531
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.632
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021901 0 0 0 0 0 40 212 22 303 42 226 56
2021/20221.306 31 6 24 59 58 68 169 221 51 128 64 427
2022/20234.045 504 352 216 259 539 456 35 235 1.311 12 92 34
2023/20241.363 79 147 48 55 132 381 59 77 25 90 113 157
2024/20254.772 52 303 317 334 357 517 149 197 788 485 382 891
2025/20266.254 840 1.049 1.356 1.231 1.469 309 0 0 0 0 0 0
Totale 24.467